Global Canine Atopic Dermatitis Market 2022-2026

Global Canine Atopic Dermatitis Market 2022-2026

Technavio has been monitoring the canine atopic dermatitis market and it is poised to grow by $ 319.37 mn during 2022-2026, progressing at a CAGR of 7.75% during the forecast period. Our report on the canine atopic dermatitis market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by increase in pet humanization and rising awareness about disease prevention and pet insurance. In addition, increase in pet humanization is anticipated to boost the growth of the market as well.

The canine atopic dermatitis market analysis includes the product segment and geographic landscape.

Technavio's canine atopic dermatitis market is segmented as below:

By Product

• Antihistamines
• Glucocorticoids
• Progestational compounds
• Others

By Geographical Landscape

• North America
• Europe
• Asia
• ROW

This study identifies the rising importance of treatment of allergic conditions in animalsas one of the prime reasons driving the canine atopic dermatitis market growth during the next few years.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on canine atopic dermatitis market covers the following areas:

• Canine atopic dermatitis market sizing
• Canine atopic dermatitis market forecast
• Canine atopic dermatitis market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading canine atopic dermatitis market vendors that include Bioceltix Spolka Akcyjna, Ceva Sante Animale, Dechra Pharmaceuticals Plc, Elanco Animal Health Inc., Novartis AG, Toray Industries Inc., Vetoquinol UK Ltd., Vimian Group AB, Virbac, and Zoetis Inc. Also, the canine atopic dermatitis market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.